Phone: 86-13209521394
Mail: sales27@interlgroup.com
Add: Room 305 , 3/F , Haipai Decoration Office Building , Yudu Avenue , Yuncheng , Shanxi
Health Product Cetilistat raw material powder
Product Overview:
Cetilistat (ATL-962), also known as Cetilistat, is a new gastrointestinal lipase inhibitor developed by the British company Alizyme. Later, "Norgina BV" obtained the global agency rights of "Cetilistat".
Health Product Cetilistat raw material powder Attributes
CAS:282526-98-1
MF:C25H39NO3
MW:401.58
EINECS:1308068-626-2
Specification: 99% min Cetilistat powder
Sample:Cetilistat powder
Packaging:1kg/bag, 25kg/drum
Brand:Global ASAP Nutrition Factory
Appearance:white
Shelf Life: 2 Years
Test Method: HPLC
Health Product Cetilistat raw material powder Details
Cetilistat powder Usage and Synthesis.
Cetirist is also known as Cetirist, Celist, and Cetirist. It is an off-white to white crystalline powder, easily soluble in methanol. Its main uses: a new type of weight-loss drug, and can be used for smoking cessation; indications: a new type of weight-loss drug, smoking cessation, lipid-lowering, and pharmaceutical raw materials.
Uses of Cetilistat powder.
Neolistat is a novel pancreatic lipase inhibitor for the treatment of obesity in diabetic and non-diabetic patients.
Drug effects of Cetilistat.
Xinlisistat is a long-acting and potent specific gastrointestinal lipase inhibitor. It exerts its therapeutic effect by forming covalent bonds with the active serine sites of gastric lipase and pancreatic lipase in the stomach and small intestine to inactivate the enzymes. The inactivated enzymes cannot hydrolyze the fat in the food, mainly triglycerides, into absorbable free fatty acids and monoacylglycerols. Undigested triglycerides cannot be absorbed by the body, thereby reducing calorie intake and controlling weight.
Pharmacological Action of Bulk Cetilistat.
Xinlisistat is a long-acting and potent specific gastrointestinal lipase inhibitor. It exerts its therapeutic effect by forming covalent bonds with the active serine sites of gastric lipase and pancreatic lipase in the stomach and small intestine to inactivate the enzymes. The inactivated enzymes cannot hydrolyze the fat in the food, mainly triglycerides, into absorbable free fatty acids and monoacylglycerols. Undigested triglycerides cannot be absorbed by the body, thereby reducing calorie intake and controlling weight.
